BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 9895043)

  • 1. The effect of cisapride on dysmotility-like functional dyspepsia: reduction of the fasting and postprandial area, but not of the postprandial antral expansion.
    Eberl T; Barnert J; Dumitrascu DL; Fischer J; Wienbeck M
    Eur J Gastroenterol Hepatol; 1998 Dec; 10(12):991-5. PubMed ID: 9895043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastric antral motility in functional dyspepsia. Effect of mental stress and cisapride.
    Hveem K; Hausken T; Svebak S; Berstad A
    Scand J Gastroenterol; 1996 May; 31(5):452-7. PubMed ID: 8734341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Wide gastric antrum in patients with non-ulcer dyspepsia. Effect of cisapride.
    Hausken T; Berstad A
    Scand J Gastroenterol; 1992 May; 27(5):427-32. PubMed ID: 1529280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dyspepsia in AIDS is correlated to ultrasonographic changes of antral distension.
    Barnert J; Dumitrascu DL; Wienbeck M
    Eur J Ultrasound; 2000 Jun; 11(3):189-97. PubMed ID: 10874194
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of metoclopramide on antral emptying of a semisolid meal in patients with functional dyspepsia. A randomized placebo controlled sonographic study.
    Dumitraşcu DL; Ungureanu O; Verzea D; Pascu O
    Rom J Intern Med; 1998; 36(1-2):97-104. PubMed ID: 10660974
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Wide gastric antrum and low vagal tone in patients with diabetes mellitus type 1 compared to patients with functional dyspepsia and healthy individuals.
    Undeland KA; Hausken T; Svebak S; Aanderud S; Berstad A
    Dig Dis Sci; 1996 Jan; 41(1):9-16. PubMed ID: 8565773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patterns of gastric emptying in dysmotility-like dyspepsia.
    Bortolotti M; Bolondi L; Santi V; Sarti P; Brunelli F; Barbara L
    Scand J Gastroenterol; 1995 May; 30(5):408-10. PubMed ID: 7638564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A double-blind fluoroscopic study of cisapride on gastrointestinal motility in patients with functional dyspepsia.
    Degryse H; De Schepper A; Verlinden M
    Scand J Gastroenterol Suppl; 1993; 195():1-4. PubMed ID: 8516652
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of glyceryl trinitrate on antral motility and symptoms in patients with functional dyspepsia.
    Hausken T; Berstad A
    Scand J Gastroenterol; 1994 Jan; 29(1):23-8. PubMed ID: 8128173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dyspepsia and dyspepsia subgroups in Japan: symptom profiles and experience with cisapride.
    Inoue M; Sekiguchi T; Harasawa S; Miwa T; Miyoshi A
    Scand J Gastroenterol Suppl; 1993; 195():36-8; discussion 38-9. PubMed ID: 8516656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia.
    Rösch W; Vinson B; Sassin I
    Z Gastroenterol; 2002 Jun; 40(6):401-8. PubMed ID: 12055663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between antral distension and postprandial symptoms in functional dyspepsia.
    Pallotta N; Pezzotti P; Corazziari E
    World J Gastroenterol; 2006 Nov; 12(43):6982-91. PubMed ID: 17109520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levosulpiride and cisapride in the treatment of dysmotility-like functional dyspepsia: a randomized, double-masked trial.
    Mearin F; Rodrigo L; Pérez-Mota A; Balboa A; Jiménez I; Sebastián JJ; Patón C
    Clin Gastroenterol Hepatol; 2004 Apr; 2(4):301-8. PubMed ID: 15067624
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional dyspepsia versus other functional gastrointestinal disorders: a practical approach in Belgian general practices.
    Verhaeghe J; Jaecques N; Rombouts J; Spaepen W; Cardon E; Lebrun F; Meurant JP
    Scand J Gastroenterol Suppl; 1993; 195():25-34; discussion 34-5. PubMed ID: 8516655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A randomized placebo-controlled trial of simethicone and cisapride for the treatment of patients with functional dyspepsia.
    Holtmann G; Gschossmann J; Mayr P; Talley NJ
    Aliment Pharmacol Ther; 2002 Sep; 16(9):1641-8. PubMed ID: 12197843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longterm oral cisapride improves interdigestive antroduodenal motility in dyspeptic patients.
    Testoni PA; Bagnolo F; Fanti L; Passaretti S; Tittobello A
    Gut; 1990 Mar; 31(3):286-90. PubMed ID: 2323591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative effects of levosulpiride and cisapride on gastric emptying and symptoms in patients with functional dyspepsia and gastroparesis.
    Mansi C; Borro P; Giacomini M; Biagini R; Mele MR; Pandolfo N; Savarino V
    Aliment Pharmacol Ther; 2000 May; 14(5):561-9. PubMed ID: 10792119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antral emptying of semisolid meal measured by real-time ultrasonography in chronic renal failure.
    Dumitrascu DL; Barnert J; Kirschner T; Wienbeck M
    Dig Dis Sci; 1995 Mar; 40(3):636-44. PubMed ID: 7895559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Correlations among electrogastrogram, gastric dysmotility, and duodenal dysmotility in patients with functional dyspepsia.
    Sha W; Pasricha PJ; Chen JD
    J Clin Gastroenterol; 2009 Sep; 43(8):716-22. PubMed ID: 19247205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rome III subgroups of functional dyspepsia exhibit different characteristics of antral contractions measured by strain rate imaging - a pilot study.
    Ahmed AB; Matre K; Hausken T; Gregersen H; Gilja OH
    Ultraschall Med; 2012 Dec; 33(7):E233-E240. PubMed ID: 23247728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.